Printed from https://ideas.repec.org/s/spr/eujhec2.html
Content
August 2022, Volume 23, Issue 6
- 1007-1014 The remarkably frequent use of EQ-5D in non-economic research
by Aimin Wang & Kim Rand & Zhihao Yang & Richard Brooks & Jan Busschbach - 1015-1035 Income level and antibiotic misuse: a systematic review and dose–response meta-analysis
by Narmeen Mallah & Nicola Orsini & Adolfo Figueiras & Bahi Takkouche - 1037-1057 Willingness-to-pay for cancer treatment and outcome: a systematic review
by Alene Sze Jing Yong & Yi Heng Lim & Mark Wing Loong Cheong & Ednin Hamzah & Siew Li Teoh - 1059-1070 Value appropriation in hepatitis C
by Peter Lindgren & Sofia Löfvendahl & Gunnar Brådvik & Ola Weiland & Bengt Jönsson - 1071-1078 Decision thresholds with genetic testing
by Stefan Felder
July 2022, Volume 23, Issue 5
- 759-761 Seeking efficiency gains outside drugs and diagnostics
by Reyes Lorente & Fernando Antonanzas - 763-779 The cost-effectiveness of unilateral cochlear implants in UK adults
by Henry Cutler & Mutsa Gumbie & Emma Olin & Bonny Parkinson & Ross Bowman & Hafsa Quadri & Timothy Mann - 781-789 What drives variations in public health and social services expenditures? the association between political fragmentation and local expenditure patterns
by Yonsu Kim & Jae Hong Kim - 791-805 Adoption of large-scale medical equipment: the impact of competition in the German inpatient sector
by Marie Dreger & Hauke Langhoff & Cornelia Henschke - 807-821 Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
by Claudine Bommer & Judith Lupatsch & Nicole Bürki & Matthias Schwenkglenks - 823-835 Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland
by Stefania Di Gangi & Christophe Bagnoud & Giuseppe Pichierri & Thomas Rosemann & Andreas Plate - 837-846 Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
by Michaela Barbier & Nicholas Durno & Craig Bennison & Mathias Örtli & Christian Knapp & Matthias Schwenkglenks - 847-861 The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups
by Hirotaka Kato & Rei Goto & Taishi Tsuji & Katsunori Kondo - 863-878 Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
by Agnes Kisser & Joschua Knieriemen & Annette Fasan & Karolin Eberle & Sara Hogger & Sebastian Werner & Tina Taube & Andrej Rasch - 879-891 One last effort. Are high out-of-pocket payments at the end of life a fatality?
by Rosalind Bell-Aldeghi & Nicolas Sirven & Morgane Guern & Christine Sevilla-Dedieu - 893-901 Work ethics, stay-at-home measures and COVID-19 diffusion
by Vincenzo Alfano - 903-912 Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures
by Abdulrahman Jbaily & Annie Haakenstad & Mizan Kiros & Carlos Riumallo-Herl & Stéphane Verguet
June 2022, Volume 23, Issue 4
- 559-563 Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective
by Javier Cifuentes-Faura & Renaud Francesco - 565-595 Short- and medium-term cost effects of non-indicated thyroid diagnostics: empirical evidence from German claims data
by Lucas Hafner & Valeria Biermann & Susann Hueber & Ewan Donnachie & Thomas Kühlein & Harald Tauchmann & Johanna Tomandl - 597-606 A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands
by Steef Redeker & Sohal Ismail & Hester V. Eeren & Emma K. Massey & Willem Weimar & Mark Oppe & Jan Busschbach - 607-615 Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
by Dan Cai & Si Shi & Shan Jiang & Lei Si & Jing Wu & Yawen Jiang - 617-625 Communities and testing for COVID-19
by Steven Stillman & Mirco Tonin - 627-643 Infections, accidents and nursing overtime in a neonatal intensive care unit
by Marc Beltempo & Georges Bresson & Jean-Michel Étienne & Guy Lacroix - 645-669 Consideration of quality of life in the health technology assessments of rare disease treatments
by Elena Nicod & Michela Meregaglia & Amanda Whittal & Sheela Upadhyaya & Karen Facey & Michael Drummond - 671-685 The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies
by Alessandra Cepparulo & Luisa Giuriato - 687-703 Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan
by Eyal Lahav & Shosh Shahrabani & Mosi Rosenboim & Yoshiro Tsutsui - 705-715 The impact of decentralisation on the performance of health care systems: a non-linear relationship
by Sean Dougherty & Luca Lorenzoni & Alberto Marino & Fabrice Murtin - 717-728 Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization
by Jonas Fooken & Varinder Jeet - 729-753 The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes
by Eline Moens & Louis Lippens & Philippe Sterkens & Johannes Weytjens & Stijn Baert - 755-756 Demonstrating the value of cancer biomarkers at the population level
by Afschin Gandjour - 757-758 Reply to comment on “Demonstrating the value of cancer biomarkers at the population”
by Ana Beatriz D’Avó Luís & Mikyung Kelly Seo
April 2022, Volume 23, Issue 3
- 329-335 Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests
by Juan Llano & Jorge Mestre-Ferrandiz & Jaime Espin & Jordi Gol-Montserrat & Alicia Llano & Carlos Bringas - 337-356 Online and offline health information seeking and the demand for physician services
by Hiroaki Suenaga & Maria Rosalía Vicente - 357-374 Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
by Lien Nguyen & Hanna Jokimäki & Ismo Linnosmaa & Eirini-Christina Saloniki & Laurie Batchelder & Juliette Malley & Hui Lu & Peter Burge & Birgit Trukeschitz & Julien Forder - 375-431 Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability
by Suaad Almajed & Nora Alotaibi & Sana Zulfiqar & Zahraa Dhuhaibawi & Niall O’Rourke & Richard Gaule & Caoimhe Byrne & Aaron M. Barry & Dylan Keeley & James F. O’Mahony - 433-451 A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)
by Darius N. Lakdawalla & Charles E. Phelps - 453-465 Does the amount of formal care affect informal care? Evidence among over-60s in France
by Elsa Perdrix & Quitterie Roquebert - 467-483 Income and conversion handicaps: estimating the impact of child chronic illness/disability on family income and the extra cost of child chronic illness/child disability in Ireland using a standard of living approach
by Áine Roddy - 485-497 The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis
by Beatriz Rodríguez-Sánchez & Luz María Peña-Longobardo & Juan Oliva-Moreno - 499-510 The impact of inpatient bed capacity on length of stay
by Brendan Walsh & Samantha Smith & Maev-Ann Wren & James Eighan & Seán Lyons - 511-535 Retirement, social support and mental well-being: a couple-level analysis
by Nathan Kettlewell & Jack Lam - 537-549 Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
by Ioanna Vlachaki & Daniela Zinzi & Edel Falla & Theo Mantopoulos & Holly Guy & Jasimran Jandu & Andrew Dodgson - 551-558 Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
by Laia Alsina & J. Bruno Montoro & Pedro Moral Moral & Olaf Neth & Marta Ortiz Pica & Silvia Sánchez-Ramón & María Presa & Itziar Oyagüez & Miguel Ángel Casado & Luis Ignacio González-Granado
March 2022, Volume 23, Issue 2
- 155-163 Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
by Elisabete Gonçalves - 165-176 Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A
by Richard Huan Xu & Anju Devianee Keetharuth & Ling-ling Wang & Annie Wai-ling Cheung & Eliza Lai-yi Wong - 177-192 The economic burden of obesity in Italy: a cost-of-illness study
by Margherita d’Errico & Milena Pavlova & Federico Spandonaro - 193-210 Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis
by Rachael Maree Hunter & Rob Anderson & Tim Kirkpatrick & Charlotte Lennox & Fiona Warren & Rod S. Taylor & Jenny Shaw & Mark Haddad & Alex Stirzaker & Mike Maguire & Richard Byng - 211-223 Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France
by Alexandre Vimont & Henri Leleu & Isabelle Durand-Zaleski - 225-235 Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores
by Krishnakumar Thankappan & Tejal Patel & Krishna Kollamparambil Ajithkumar & Deepak Balasubramanian & Manu Raj & Sujha Subramanian & Subramania Iyer - 237-248 Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium
by Désirée Vandenberghe - 249-259 The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study
by Paul Hanly & Michelle Ahern & Linda Sharp & Diana Ursul & Gerard Loughnane - 261-275 Is prevention of suicide worth less? A comparison of the value per statistical life
by Vimefall Elin & Persson Mattias & Olofsson Sara & Hultkrantz Lars - 277-299 Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
by Christian R. C. Kouakou & Thomas G. Poder - 301-312 The contribution of resident physicians to hospital productivity
by Maria J. Perez-Villadóniga & Ana Rodriguez-Alvarez & David Roibas - 313-327 Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016
by Lukas Schuelke & Luke Munford & Marcello Morciano
February 2022, Volume 23, Issue 1
- 1-5 The Italian NHS at regional level: same in theory, different in practice
by Livio Garattini & Marco Badinella Martini & Michele Zanetti - 7-22 Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China
by Wen He - 23-32 Costs and management of patients with hemophilia A in France: the Hemraude study
by C. Laurendeau & J. Goudemand & M. Trossaert & B. Polack & R. Varin & C. Godard & F. Hadim & B. Detournay - 33-45 Production losses due to mortality associated with modifiable health risk factors in Poland
by Błażej Łyszczarz & Karolina Sowa - 47-57 HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm
by Ana Sofia Oliveira Gonçalves & Dimitra Panteli & Lars Neeb & Tobias Kurth & Annette Aigner - 59-65 Effects of provider incentives on dental X-raying in NHS Scotland: what happens if patients switch providers?
by Olivier Kalmus & Martin Chalkley & Stefan Listl - 67-80 The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study
by Josephine Storch & Carolin Fleischmann-Struzek & Norman Rose & Thomas Lehmann & Anna Mikolajetz & Srikanth Maddela & Mathias W. Pletz & Christina Forstner & Ole Wichmann & Julia Neufeind & Monique Vogel & Konrad Reinhart & Horst Christian Vollmar & Antje Freytag - 81-94 Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?
by Sebastian Himmler & Job Exel & Werner Brouwer - 95-104 The impact of cancellations in waiting times analysis: evidence from scheduled surgeries in the Portuguese NHS
by Joana Cima & Álvaro Almeida - 105-117 Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis
by Amit Summan & Arindam Nandi - 119-131 Health effects from heat waves in France: an economic evaluation
by Lucie Adélaïde & Olivier Chanel & Mathilde Pascal - 133-151 Use of past care markers in risk-adjustment: accounting for systematic differences across providers
by Laura Anselmi & Yiu-Shing Lau & Matt Sutton & Anna Everton & Rob Shaw & Stephen Lorrimer - 153-153 Correction to: The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study
by Paul Hanly & Michelle Ahern & Linda Sharp & Diana Ursul & Gerard Loughnane
December 2021, Volume 22, Issue 9
- 1345-1348 Pricing vaccines and drugs in Europe: worth differentiating?
by Livio Garattini & Anna Padula & Nicholas Freemantle - 1349-1363 The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups
by V. Lorenzoni & G. Barbieri & F. Saia & F. Meucci & G. L. Martinelli & A. G. Cerillo & S. Berti & P. Candolfi & G. Turchetti - 1365-1370 Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis
by Ian Grady & Sean Grady & Nailya Chanisheva - 1371-1379 Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
by A. Marcellusi & F. S. Mennini & P. Sciattella & G. Favato - 1381-1391 Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly
by Kailu Wang & Xiaopeng Guo & Siyue Yu & Lu Gao & Zihao Wang & Huijuan Zhu & Bing Xing & Shuyang Zhang & Dong Dong - 1393-1409 The effects of health shocks on family status: do financial incentives encourage marriage?
by Andree Ehlert - 1411-1425 Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana
by Isaac Koomson & Abdallah Abdul-Mumuni & Anthony Abbam - 1427-1439 Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues
by Ugur Korkut Pata - 1441-1451 Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial
by Nathan S. McClure & Mike Paulden & Arto Ohinmaa & Jeffrey A. Johnson - 1453-1466 Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population
by Petra Baji & Miklós Farkas & Ágota Dobos & Zsombor Zrubka & Levente Kovács & László Gulácsi & Márta Péntek - 1467-1475 General population normative data for the EQ-5D-3L in the five largest European economies
by Mathieu F. Janssen & A. Simon Pickard & James W. Shaw - 1477-1485 A direct method for the identification of patterns of care using administrative databases: the case of breast cancer
by Susanna Busco & Andrea Tavilla & Anna Gigli & Tania Lopez & Daniela Pierannunzio & Sandra Mallone & Stefano Guzzinati & Giulia Capodaglio & Francesco Giusti & Catia Angiolini & Silvia Francisci - 1487-1505 The costs of celiac disease: a contingent valuation in Switzerland
by Laia Soler & Nicolas Borzykowski - 1507-1518 Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states
by S. A. Lipman & V. T. Reckers-Droog & M. Karimi & M. Jakubczyk & A. E. Attema - 1519-1533 The effect of mental and physical health problems on sickness absence
by Mark L. Bryan & Andrew M. Bryce & Jennifer Roberts
November 2021, Volume 22, Issue 8
- 1141-1150 Structural factors and integrated care interventions: is there a role for economists in the policy debate?
by Luke B. Connelly & Gianluca Fiorentini - 1151-1166 The economic burden of amyotrophic lateral sclerosis: a systematic review
by K. Achtert & L. Kerkemeyer - 1167-1181 Complements or substitutes? Associations between volumes of care provided in the community and hospitals
by Yiu-Shing Lau & Gintare Malisauskaite & Nadia Brookes & Shereen Hussein & Matt Sutton - 1183-1194 Unpacking the red packets: institution and informal payments in healthcare in China
by Ning Liu & Zhuo Chen & Guoxian Bao - 1195-1216 Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals
by André Madeira & Victor Moutinho & José Alberto Fuinhas - 1217-1237 The role of health at birth and parental investment in early child development: evidence from the French ELFE cohort
by Marion Davin & Emmanuelle Lavaine - 1239-1251 On the correlation between outcome indicators and the structure and process indicators used to proxy them in public health care reporting
by Benjamin H. Salampessy & France R. M. Portrait & Eric Hijden & Ab Klink & Xander Koolman - 1253-1273 Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
by Carlo Federici & Vivian Reckers-Droog & Oriana Ciani & Florian Dams & Bogdan Grigore & Zoltán Kaló & Sándor Kovács & Kosta Shatrov & Werner Brouwer & Michael Drummond - 1275-1288 Health state utility values by cancer stage: a systematic literature review
by Mir-Masoud Pourrahmat & Ashley Kim & Anuraag R. Kansal & Marg Hux & Divya Pushkarna & Mir Sohail Fazeli & Karen C. Chung - 1289-1299 Business cycle and mortality in Spain
by María Cervini-Plá & Judit Vall-Castelló - 1301-1309 Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
by Koonal K. Shah & Bryan Bennett & Andrew Lenny & Louise Longworth & John E. Brazier & Mark Oppe & A. Simon Pickard & James W. Shaw - 1311-1344 Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies
by Nikolai Mühlberger & Gaby Sroczynski & Artemisa Gogollari & Beate Jahn & Nora Pashayan & Ewout Steyerberg & Martin Widschwendter & Uwe Siebert
September 2021, Volume 22, Issue 7
- 1001-1004 COVID-19: not the time for health economists? A plea for more proactive health economic involvement
by J.-Matthias Graf von der Schulenburg - 1005-1016 How the COVID-19 pandemic can distort risk adjustment of health plan payment
by Richard C. Kleef & Mieke Reuser - 1017-1024 The impact of COVID-19 pandemic on insurance demand: the case of China
by Xianhang Qian - 1025-1038 Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections
by Donatella Saccone - 1039-1052 Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study
by Audrey Tanguy-Melac & Dorian Verboux & Laurence Pestel & Anne Fagot-Campagna & Philippe Tuppin & Christelle Gastaldi-Ménager - 1053-1065 Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark
by Ziggi Ivan Santini & Hannah Becher & Maja Bæksgaard Jørgensen & Michael Davidsen & Line Nielsen & Carsten Hinrichsen & Katrine Rich Madsen & Charlotte Meilstrup & Ai Koyanagi & Sarah Stewart-Brown & David McDaid & Vibeke Koushede - 1067-1081 What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?
by Tessa Peasgood & Clara Mukuria & Jill Carlton & Janice Connell & Nancy Devlin & Karen Jones & Rosemary Lovett & Bhash Naidoo & Stacey Rand & Juan Carlos Rejon-Parrilla & Donna Rowen & Aki Tsuchiya & John Brazier - 1083-1093 Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China
by Wang Pei & Sun Yue & Yang Zhi-Hao & Zhang Ruo-Yu & Wu Bin & Luo Nan - 1095-1101 Obesity Kuznets curve and the reality of eco-income ellipsoids (EIE)
by Andrew Adewale Alola & Festus Victor Bekun - 1103-1113 Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies
by Wenjing Zhou & Anle Shen & Zhihao Yang & Pei Wang & Bin Wu & Michael Herdman & Nan Luo - 1115-1128 Assessing the consequences of quarantines during a pandemic
by Rikard Forslid & Mathias Herzing - 1129-1139 The relationship between renewable energy use and health expenditures in EU countries
by Mahmut Unsal Sasmaz & Aysun Karamıklı & Ulas Akkucuk
August 2021, Volume 22, Issue 6
- 851-854 Something borrowed, something new: measuring hospital performance in the context of value based health care
by Peter Lindgren & Rikard Althin - 855-864 Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting
by Arnaud Bayle & N. Droin & B. Besse & Z. Zou & Y. Boursin & S. Rissel & E. Solary & L. Lacroix & E. Rouleau & I. Borget & J. Bonastre - 865-872 Comparison of self-reported and public registered absenteeism among people on long-term sick leave due to musculoskeletal disorders: criterion validity of the iMTA Productivity Cost Questionnaire
by Rikke Munk Killingmo & Anne Therese Tveter & Milada C. Småstuen & Kjersti Storheim & Margreth Grotle - 873-885 Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data
by Claudia Schulz & Gisela Büchele & Raphael S. Peter & Dietrich Rothenbacher & Christian Brettschneider & Ulrich C. Liener & Clemens Becker & Kilian Rapp & Hans-Helmut König - 887-903 Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary
by Anikó Bíró & Ágnes Szabó-Morvai - 905-915 The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary
by Christoph F. Kurz & Adriana N. König - 917-929 Regional medical practice variation in high-cost healthcare services
by Michael Berger & Thomas Czypionka - 931-949 Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
by Snorre Kverndokk & Hans Olav Melberg - 951-960 Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits
by Ruben Willems & Fouke Ombelet & Eva Goossens & Katya De Groote & Werner Budts & Stéphane Moniotte & Michèle de Hosson & Liesbet Van Bulck & Ariane Marelli & Philip Moons & Julie De Backer & Lieven Annemans - 961-975 Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review
by Kristina Kast & Carl-Philipp Wachter & Oliver Schöffski & Martina Rimmele - 977-989 Home sweet home: GPs’ response to an increase in the fee size for home visits
by Jamie O’Halloran & Anne Sophie Oxholm & Line Bjørnskov Pedersen & Dorte Gyrd-Hansen - 991-999 Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
by Marije E. Hagendijk & Simon Schans & Cornelis Boersma & Maarten J. Postma & Simon Pol
July 2021, Volume 22, Issue 5
- 661-667 The “red herring” after 20 years: ageing and health care expenditures
by Friedrich Breyer & Normann Lorenz - 669-677 A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland
by Michaela Carla Barbier & Esther Pardo & Cédric Michael Panje & Oliver Gautschi & Judith Eva Lupatsch - 679-697 Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others
by Sebastian Neumann-Böhme & Stefan A. Lipman & Werner B. F. Brouwer & Arthur E. Attema - 699-709 How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach
by Shuli Brammli-Greenberg & Ira Yaari & Elad Daniels & Ariella Adijes-Toren - 711-721 Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses
by Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi - 723-733 Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists
by Michael J. Zoratti & A. Simon Pickard & Peep F. M. Stalmeier & Daniel Ollendorf & Andrew Lloyd & Kelvin K W Chan & Don Husereau & John E. Brazier & Murray Krahn & Mitchell Levine & Lehana Thabane & Feng Xie - 735-747 Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients
by Asrul Akmal Shafie & Irwinder Kaur Chhabra & Jacqueline Hui Yi Wong & Noor Syahireen Mohammed - 749-771 Are long-term care jobs harmful? Evidence from Germany
by Thomas Rapp & Jérôme Ronchetti & Jonathan Sicsic - 773-788 Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates
by Samer A. Kharroubi & Yara Beyh - 789-810 Has the development of cancer biomarkers to guide treatment improved health outcomes?
by Ana Beatriz D′Avó Luís & Mikyung Kelly Seo - 811-831 Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices
by Jean Spinks & Son Nghiem & Joshua Byrnes - 833-846 The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach
by Karina Dietermann & Vera Winter & Udo Schneider & Jonas Schreyögg - 847-847 Correction to: A general framework for classifying costing methods for economic evaluation of health care
by Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín - 849-849 Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease
by L. M. Peña-Longobardo & B. Rodríguez-Sánchez & J. Oliva-Moreno & I. Aranda-Reneo & J. López-Bastida
June 2021, Volume 22, Issue 4
- 499-504 Awaiting the “catharsis”
by John Yfantopoulos - 505-518 Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
by Alice Morgan & Sally Hartmanis & Emmanuel Tsochatzis & Philip N. Newsome & Stephen D. Ryder & Rachel Elliott & Lefteris Floros & Richard Hall & Victoria Higgins & George Stanley & Sandrine Cure & Sharad Vasudevan & Lynne Pezzullo - 519-529 Beyond price: the effects of non-financial barriers on access to drugs and health outcomes
by Lucia Leporatti & Rosella Levaggi & Marcello Montefiori - 531-545 Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study
by Ina Rissanen & Leena Ala-Mursula & Iiro Nerg & Marko Korhonen - 547-557 Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia
by Richard Huan Xu & Dong Dong & Nan Luo & Eliza Lai-Yi Wong & Yushan Wu & Siyue Yu & Renchi Yang & Junshuai Liu & Huiqin Yuan & Shuyang Zhang - 559-569 The economics of alternative payment models for pharmaceuticals
by Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla - 571-584 Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations
by Kamolpat Chaiyakittisopon & Oraluck Pattanaprateep & Narisa Ruenroengbun & Tunlanut Sapankaew & Atiporn Ingsathit & Gareth J. Mckay & John Attia & Ammarin Thakkinstian - 585-604 Economic analysis of open versus laparoscopic versus robotic hepatectomy: a systematic review and meta-analysis
by Ioannis A. Ziogas & Alexandros P. Evangeliou & Konstantinos S. Mylonas & Dimitrios I. Athanasiadis & Panagiotis Cherouveim & David A. Geller & Richard D. Schulick & Sophoclis P. Alexopoulos & Georgios Tsoulfas - 605-620 The cost of chemotherapy administration: a systematic review and meta-analysis
by Gursharan K. Sohi & Jordan Levy & Victoria Delibasic & Laura E. Davis & Alyson L. Mahar & Elmira Amirazodi & Craig C. Earle & Julie Hallet & Ahmed Hammad & Rajan Shah & Nicole Mittmann & Natalie G. Coburn - 621-628 Comparison of the three-level and the five-level versions of the EQ-5D
by Anne Simone Juhl Christiansen & Marie Louise Sletskov Møller & Christian Kronborg & Ketil Jørgen Haugan & Lars Køber & Søren Højberg & Axel Brandes & Claus Graff & Søren Zöga Diederichsen & Jonas Bille Nielsen & Derk Krieger & Anders Gaarsdal Holst & Jesper Hastrup Svendsen - 629-642 Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe
by Mounir Amdaoud & Giuseppe Arcuri & Nadine Levratto - 643-658 Rising unemployment reduces the demand for healthcare services among people with cardiovascular disease: an Australian cohort study
by Clifford Afoakwah & Son Nghiem & Paul Scuffham & Joshua Byrnes - 659-660 Correction to: Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort
by Dmitrij Achelrod & Jonas Schreyögg & Tom Stargardt
April 2021, Volume 22, Issue 3
- 351-355 Accountability for an unhealthy lifestyle
by Daniel M. Campagne - 357-363 Discounting in economic evaluation of healthcare interventions: what about the risk term?
by Lars Hultkrantz - 365-380 German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life
by Judith Dams & Elisabeth Huynh & Steffi Riedel-Heller & Margrit Löbner & Christian Brettschneider & Hans-Helmut König - 381-392 The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers?
by Luke B. Wilson & Robert Pryce & Colin Angus & Rosemary Hiscock & Alan Brennan & Duncan Gillespie - 393-403 Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer
by Eduard Vrdoljak & Mario Sekerija & Stjepko Plestina & Ingrid Belac Lovasic & Vera Katalinic Jankovic & Livio Garattini & Ana Bobinac & Luka Voncina - 405-423 Health measures and long-term care use in the European frail population
by Quitterie Roquebert & Jonathan Sicsic & Thomas Rapp - 425-443 Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment
by Axel C. Mühlbacher & Andrew Sadler & Christin Juhnke - 445-454 Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region
by Jad Shedrawy & Charlotte Deogan & Joanna Nederby Öhd & Maria-Pia Hergens & Judith Bruchfeld & Jerker Jonsson & Andrew Siroka & Knut Lönnroth - 455-462 COVID-19 and income inequality in OECD countries
by John Wildman - 463-471 Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis
by Yue Zhou & Haishaerjiang Wushouer & Daniel Vuillermin & Xiaodong Guan & Luwen Shi - 473-483 The impact of social health insurance on rural populations
by Colin Green & Bruce Hollingsworth & Miaoqing Yang - 485-497 Economic and social cost of epilepsy in Poland: 5-year analysis
by Joanna Jędrzejczak & Beata Majkowska-Zwolińska & Anna Chudzicka-Bator & Iwona Żerda & Magdalena Władysiuk & Brian Godman
March 2021, Volume 22, Issue 2
- 183-186 More room for telemedicine after COVID-19: lessons for primary care?
by Livio Garattini & Marco Badinella Martini & Michele Zanetti - 187-193 Revisiting the Swedish alcohol stasis after changes in travelers’ allowances in 2004: petrol prices provide a piece of the puzzle
by Stefan K. Lhachimi - 195-221 Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition
by Michael Stucki - 223-228 Sex differences in cigarette brand purchases among adult smokers: results from the DePICT national repeated survey of French adults (2016–2017)
by Fabienne El-Khoury Lesueur & Hugo Torregrossa & Ramchandar Gomajee & Camille Bolze & Maria Melchior - 229-242 Does NICE influence the adoption and uptake of generics in the UK?
by Victoria Serra-Sastre & Simona Bianchi & Jorge Mestre-Ferrandiz & Phill O’Neill - 243-254 Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events
by Fränce Hardtstock & Zeki Kocaata & Thomas Wilke & Axel Dittmar & Marco Ghiani & Vasily Belozeroff & David J. Harrison & Ulf Maywald & Hans Tesch - 255-266 Employer survey to estimate the productivity friction period
by Kathleen Manipis & Stephen Goodall & Paul Hanly & Rosalie Viney & Alison Pearce - 267-279 Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–2015
by Peipei Chai & Quan Wan & Yohannes Kinfu - 281-309 Voluntary private health insurance, health-related behaviours and health outcomes: evidence from Russia
by Andrey Aistov & Ekaterina Aleksandrova & Christopher J. Gerry - 311-327 COVID-19 and the role of inequality in French regional departments
by Victor Ginsburgh & Glenn Magerman & Ilaria Natali - 329-339 Does socioeconomic status affect hospital utilization and health outcomes of chronic disease patients?
by Jongsay Yong & Ou Yang - 341-350 Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique
by Lan Gao & Wei Luo & Utsana Tonmukayakul & Marj Moodie & Gang Chen
February 2021, Volume 22, Issue 1
- 1-4 Do European pharmacists really have to trespass on medicine?
by Livio Garattini & Anna Padula & Nicholas Freemantle - 5-16 ‘Relative Consent’ or ‘Presumed Consent’? Organ donation attitudes and behaviour
by Joan Costa-Font & Caroline Rudisill & Maximilian Salcher-Konrad - 17-33 Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality
by Ruixuan Jiang & Thomas Kohlmann & Todd A. Lee & Axel Mühlbacher & James Shaw & Surrey Walton & A. Simon Pickard - 35-50 Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces
by Thomas G. McGuire & Sonja Schillo & Richard C. Kleef - 51-73 A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England
by Nasuh C. Buyukkaramikli & Peter Wigfield & Men Thi Hoang - 75-88 Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
by Job F. H. Eijsink & Mohamed N. M. T. Al Khayat & Cornelis Boersma & Peter G. J. Horst & Jan C. Wilschut & Maarten J. Postma - 89-100 A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme
by Martin Connock & Peter Auguste & Xavier Armoiry - 101-114 Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany?
by Clara Pott & Tom Stargardt & Udo Schneider & Simon Frey - 115-139 Accreditation as a quality-improving policy tool: family planning, maternal health, and child health in Egypt
by Amira El-Shal & Patricia Cubi-Molla & Mireia Jofre-Bonet - 141-153 Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal
by Aida Isabel Tavares & Inês Marques - 155-168 The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data
by Lluc Puig-Codina & Jaime Pinilla & Jaume Puig-Junoy - 169-180 Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease
by Frida Schain & Nurgul Batyrbekova & Johan Liwing & Simona Baculea & Thomas Webb & Mats Remberger & Jonas Mattsson - 181-181 Correction to: Healthcare expenditure and carbon footprint in the USA: evidence from hidden cointegration approach
by Murat Gündüz
December 2020, Volume 21, Issue 9
- 1273-1277 Efficiency ratio and rocketing drug prices: old concerns and new possibilities
by Stefano Capri & Fernando Antonanzas - 1279-1293 The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada
by Thaksha Thavam & Rose Anne Devlin & Amardeep Thind & Gregory S. Zaric & Sisira Sarma - 1295-1315 General practitioners’ income and activity: the impact of multi-professional group practice in France
by Matthieu Cassou & Julien Mousquès & Carine Franc - 1317-1327 Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
by Laura Pirhonen & Hanna Gyllensten & Andreas Fors & Kristian Bolin - 1329-1350 Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature
by Klas Kellerborg & Werner Brouwer & Pieter Baal - 1351-1361 Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany
by Edin Basic & Mathias Kappel & Arpit Misra & Leopold Sellner & Boris A. Ratsch & Dennis A. Ostwald - 1363-1373 Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas
by Richard Huan Xu & Eliza Lai Yi Wong & Jun Jin & Ying Dou & Dong Dong - 1375-1389 No gain in pain: psychological well-being, participation, and wages in the BHPS
by Elena Lagomarsino & Alessandro Spiganti - 1391-1398 How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use
by Julien Silhol & Bruno Ventelou & Anna Zaytseva - 1399-1410 Timing matters: worker absenteeism in a weekly backward rotating shift model
by Bernd Frick & Robert Simmons & Friedrich Stein - 1411-1420 Multiplicative modelling of EQ-5D-3L TTO and VAS values
by Asrul Akmal Shafie & Annushiah Vasan Thakumar - 1421-1437 HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
by Doug Coyle & Isabelle Durand-Zaleski & Jasmine Farrington & Louis Garrison & Johann-Matthias Graf von der Schulenburg & Wolfgang Greiner & Louise Longworth & Aurélie Meunier & Anne-Sophie Moutié & Stephen Palmer & Zack Pemberton-Whiteley & Mark Ratcliffe & Jie Shen & Doug Sproule & Kun Zhao & Koonal Shah
November 2020, Volume 21, Issue 8
- 1117-1120 Should health technology assessment be more patient centric? If so, how?
by Michael Drummond & Aleksandra Torbica & Rosanna Tarricone - 1121-1129 Using machine learning to assess the predictive potential of standardized nursing data for home healthcare case-mix classification
by Maud H. Korte & Gertjan S. Verhoeven & Arianne M. J. Elissen & Silke F. Metzelthin & Dirk Ruwaard & Misja C. Mikkers - 1131-1147 The effect of long-term care public benefits and insurance on informal care from outside the household: empirical evidence from Italy and Spain
by Christophe Courbage & Guillem Montoliu-Montes & Joël Wagner